2023
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
Omran S, Shu L, Chang A, Parikh N, Zubair A, Simpkins A, Heldner M, Hakim A, Al Kasab S, Nguyen T, Klein P, Goldstein E, Vedovati M, Paciaroni M, Liebeskind D, Yaghi S, Cutting S. Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis. Journal Of Stroke 2023, 25: 291-298. PMID: 37282376, PMCID: PMC10250867, DOI: 10.5853/jos.2023.00213.Peer-Reviewed Original ResearchCerebral venous thrombosisPredictors of recanalizationVenous thrombosisMale sexMultivariable analysisParenchymal changesOlder ageTiming of recanalizationVenous thrombosis studyLarge prospective studiesCVT diagnosisFurther recanalizationComplete recanalizationAnticoagulation treatmentConsecutive patientsDisease courseIndependent predictorsVessel recanalizationBaseline imagingInitial diagnosisMedian timeProspective studyPrespecified variablesThrombosis StudyFavorable outcome
2022
Characteristics and outcomes of postpartum cerebral venous sinus thrombosis: A subgroup analysis of the ACTION-CVT study
Fang T, Shu L, Elnazeir M, Zubair AS, Al Kasab S, Antonenko K, Heldner MR, Yaghi S, Henninger N, collaborators A. Characteristics and outcomes of postpartum cerebral venous sinus thrombosis: A subgroup analysis of the ACTION-CVT study. Journal Of Stroke And Cerebrovascular Diseases 2022, 31: 106865. PMID: 36332527, DOI: 10.1016/j.jstrokecerebrovasdis.2022.106865.Peer-Reviewed Original ResearchConceptsCerebral venous sinus thrombosisVenous sinus thrombosisSinus thrombosisMajor hemorrhageNon-postpartum womenVenous thrombosis studyTreatment-related complicationsVenous thromboembolism recurrenceOne-year outcomesOne-year riskLong-term outcomesNon-pregnant femalesCause deathThromboembolism recurrenceVTE recurrenceEarly complicationsDischarge dispositionRankin ScaleSecondary outcomesVenous infarctionPostpartum statusPrimary outcomeFunctional disabilityIntracranial hemorrhagePotential confounders
2011
“Change, before you have to.”–Jack Welch, Former CEO, General Electric*
Faustino EV, Lawson KA, Northrup V, Higgerson RA. “Change, before you have to.”–Jack Welch, Former CEO, General Electric*. Critical Care Medicine 2011, 40: 2227-2228. PMID: 21336130, PMCID: PMC3101274, DOI: 10.1097/ccm.0b013e31820eb8a1.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAge FactorsCase-Control StudiesCatheterization, Central VenousCause of DeathChildChild, PreschoolCritical CareCritical IllnessFemaleHospital MortalityHumansInfantIntensive Care Units, PediatricMalePrognosisReference ValuesRespiration, ArtificialRetrospective StudiesRisk AssessmentSex FactorsSurvival AnalysisTime FactorsTreatment OutcomeVenous ThrombosisConceptsVentilator-free daysIntensive care unitCentral venous lineDeep venous thrombosisDeep vein thrombosisIndex patientsVenous thrombosisCare unitMechanical ventilationIll childrenControl patientsVein thrombosisVenous lineIntensive care unit-free daysIntensive care unit stayPrevious prospective observational studyPediatric intensive care unitCentral venous line insertionSymptomatic venous thromboembolismVenous thrombosis studyProspective observational studyAlternative outcome measuresUnit stayVenous thromboembolismCohort study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply